APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DNA Repair Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DNA Repair Drugs Market Outlook and Growth Opportunities 2026

Report ID 173985380419 December 2025207 pages

Choose your research edition.

Industry ResearchDNA Repair Drugs Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Repair Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal DNA Repair Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Repair Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Repair Drugs Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global DNA Repair Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA Repair Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA Repair Drugs market include Johnson & Johnson, Jiangsu Hengrui Medicine, GlaxoSmithKline, Tesaro, National Institutes of Health, National Health Service, KuDOS Pharmaceuticals, Karyopharm Therapeutics and Jonsson Comprehensive Cancer Center, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DNA Repair Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Repair Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Repair Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DNA Repair Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

DNA Repair Drugs Segment by Company

Johnson & Johnson

Jiangsu Hengrui Medicine

GlaxoSmithKline

Tesaro

National Institutes of Health

National Health Service

KuDOS Pharmaceuticals

Karyopharm Therapeutics

Jonsson Comprehensive Cancer Center

German Breast Group

Georgetown University

Genentech

Cambridge University Hospitals NHS Foundation Trust

British Columbia Cancer Agency

Bristol Myers Squibb

ARCAGY/ GINECO GROUP

4SC AG

DNA Repair Drugs Segment by Type

PARP Inhibitors

Other

DNA Repair Drugs Segment by Application

Oncological

Stroke

DNA Repair Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global DNA Repair Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions DNA Repair Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Repair Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Repair Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Repair Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Repair Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Repair Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DNA Repair Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Repair Drugs industry.

Chapter 3: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of DNA Repair Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of DNA Repair Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Repair Drugs Industry Trends Table 2. DNA Repair Drugs Industry Drivers Table 3. DNA Repair Drugs Industry Opportunities and Challenges Table 4. DNA Repair Drugs Industry Restraints Table 5. Global DNA Repair Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Repair Drugs Revenue Share by Company (2021-2026) Table 7. Global DNA Repair Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global DNA Repair Drugs Sales Volume Share by Company (2021-2026) Table 9. Global DNA Repair Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global DNA Repair Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global DNA Repair Drugs Key Company Manufacturing Base & Headquarters Table 12. Global DNA Repair Drugs Company, Product Type & Application Table 13. Global DNA Repair Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PARP Inhibitors Table 18. Significant Companies of Other Table 19. Global DNA Repair Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global DNA Repair Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global DNA Repair Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global DNA Repair Drugs Sales Volume Share by Type (2021-2026) Table 23. Global DNA Repair Drugs Sales Volume Share by Type (2027-2032) Table 24. Global DNA Repair Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global DNA Repair Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global DNA Repair Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global DNA Repair Drugs Sales Value Share by Type (2021-2026) Table 28. Global DNA Repair Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oncological Table 30. Significant Companies of Stroke Table 31. Global DNA Repair Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global DNA Repair Drugs Sales Volume by Application (2021-2026) & (K Units) Table 33. Global DNA Repair Drugs Sales Volume by Application (2027-2032) & (K Units) Table 34. Global DNA Repair Drugs Sales Volume Share by Application (2021-2026) Table 35. Global DNA Repair Drugs Sales Volume Share by Application (2027-2032) Table 36. Global DNA Repair Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global DNA Repair Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global DNA Repair Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global DNA Repair Drugs Sales Value Share by Application (2021-2026) Table 40. Global DNA Repair Drugs Sales Value Share by Application (2027-2032) Table 41. Global DNA Repair Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global DNA Repair Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global DNA Repair Drugs Sales Market Share by Region (2021-2026) Table 44. Global DNA Repair Drugs Sales by Region (2027-2032) & (K Units) Table 45. Global DNA Repair Drugs Sales Market Share by Region (2027-2032) Table 46. Global DNA Repair Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global DNA Repair Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global DNA Repair Drugs Sales Value Share by Region (2021-2026) Table 49. Global DNA Repair Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global DNA Repair Drugs Sales Value Share by Region (2027-2032) Table 51. Global DNA Repair Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global DNA Repair Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global DNA Repair Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global DNA Repair Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global DNA Repair Drugs Sales by Country (2021-2026) & (K Units) Table 56. Global DNA Repair Drugs Sales Market Share by Country (2021-2026) Table 57. Global DNA Repair Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global DNA Repair Drugs Sales Market Share by Country (2027-2032) Table 59. Global DNA Repair Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global DNA Repair Drugs Sales Value Market Share by Country (2021-2026) Table 61. Global DNA Repair Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global DNA Repair Drugs Sales Value Market Share by Country (2027-2032) Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson DNA Repair Drugs Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Jiangsu Hengrui Medicine Company Information Table 69. Jiangsu Hengrui Medicine Business Overview Table 70. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio Table 72. Jiangsu Hengrui Medicine Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline DNA Repair Drugs Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. Tesaro Company Information Table 79. Tesaro Business Overview Table 80. Tesaro DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Tesaro DNA Repair Drugs Product Portfolio Table 82. Tesaro Recent Development Table 83. National Institutes of Health Company Information Table 84. National Institutes of Health Business Overview Table 85. National Institutes of Health DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. National Institutes of Health DNA Repair Drugs Product Portfolio Table 87. National Institutes of Health Recent Development Table 88. National Health Service Company Information Table 89. National Health Service Business Overview Table 90. National Health Service DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. National Health Service DNA Repair Drugs Product Portfolio Table 92. National Health Service Recent Development Table 93. KuDOS Pharmaceuticals Company Information Table 94. KuDOS Pharmaceuticals Business Overview Table 95. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio Table 97. KuDOS Pharmaceuticals Recent Development Table 98. Karyopharm Therapeutics Company Information Table 99. Karyopharm Therapeutics Business Overview Table 100. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Karyopharm Therapeutics DNA Repair Drugs Product Portfolio Table 102. Karyopharm Therapeutics Recent Development Table 103. Jonsson Comprehensive Cancer Center Company Information Table 104. Jonsson Comprehensive Cancer Center Business Overview Table 105. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio Table 107. Jonsson Comprehensive Cancer Center Recent Development Table 108. German Breast Group Company Information Table 109. German Breast Group Business Overview Table 110. German Breast Group DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. German Breast Group DNA Repair Drugs Product Portfolio Table 112. German Breast Group Recent Development Table 113. Georgetown University Company Information Table 114. Georgetown University Business Overview Table 115. Georgetown University DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Georgetown University DNA Repair Drugs Product Portfolio Table 117. Georgetown University Recent Development Table 118. Genentech Company Information Table 119. Genentech Business Overview Table 120. Genentech DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Genentech DNA Repair Drugs Product Portfolio Table 122. Genentech Recent Development Table 123. Cambridge University Hospitals NHS Foundation Trust Company Information Table 124. Cambridge University Hospitals NHS Foundation Trust Business Overview Table 125. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio Table 127. Cambridge University Hospitals NHS Foundation Trust Recent Development Table 128. British Columbia Cancer Agency Company Information Table 129. British Columbia Cancer Agency Business Overview Table 130. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. British Columbia Cancer Agency DNA Repair Drugs Product Portfolio Table 132. British Columbia Cancer Agency Recent Development Table 133. Bristol Myers Squibb Company Information Table 134. Bristol Myers Squibb Business Overview Table 135. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Bristol Myers Squibb DNA Repair Drugs Product Portfolio Table 137. Bristol Myers Squibb Recent Development Table 138. ARCAGY/ GINECO GROUP Company Information Table 139. ARCAGY/ GINECO GROUP Business Overview Table 140. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio Table 142. ARCAGY/ GINECO GROUP Recent Development Table 143. 4SC AG Company Information Table 144. 4SC AG Business Overview Table 145. 4SC AG DNA Repair Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. 4SC AG DNA Repair Drugs Product Portfolio Table 147. 4SC AG Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. DNA Repair Drugs Distributors List Table 151. DNA Repair Drugs Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. DNA Repair Drugs Product Image Figure 2. Global DNA Repair Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Repair Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global DNA Repair Drugs Sales (2021-2032) & (K Units) Figure 5. Global DNA Repair Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global DNA Repair Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PARP Inhibitors Image Figure 10. Other Image Figure 11. Global DNA Repair Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global DNA Repair Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global DNA Repair Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global DNA Repair Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global DNA Repair Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global DNA Repair Drugs Sales Value Share by Type (2021-2032) Figure 17. Oncological Image Figure 18. Stroke Image Figure 19. Global DNA Repair Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global DNA Repair Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global DNA Repair Drugs Sales Volume Share by Application (2021-2032) Figure 22. Global DNA Repair Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global DNA Repair Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global DNA Repair Drugs Sales Value Share by Application (2021-2032) Figure 25. Global DNA Repair Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global DNA Repair Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global DNA Repair Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global DNA Repair Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America DNA Repair Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. North America DNA Repair Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe DNA Repair Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Europe DNA Repair Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific DNA Repair Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific DNA Repair Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America DNA Repair Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. South America DNA Repair Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa DNA Repair Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa DNA Repair Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt DNA Repair Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. DNA Repair Drugs Value Chain Figure 124. Manufacturing Cost Structure Figure 125. DNA Repair Drugs Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • PARP Inhibitors
  • Other
Applications
  • Oncological
  • Stroke
Companies covered
  • Johnson & Johnson
  • Jiangsu Hengrui Medicine
  • GlaxoSmithKline
  • Tesaro
  • National Institutes of Health
  • National Health Service
  • KuDOS Pharmaceuticals
  • Karyopharm Therapeutics
  • Jonsson Comprehensive Cancer Center
  • German Breast Group
  • Georgetown University
  • Genentech
  • Cambridge University Hospitals NHS Foundation Trust
  • British Columbia Cancer Agency
  • Bristol Myers Squibb
  • ARCAGY/ GINECO GROUP
  • 4SC AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DNA Repair Drugs Sales Value (2021-2032)
  4. 1.2.2 Global DNA Repair Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global DNA Repair Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 DNA Repair Drugs Market Dynamics
  1. 2.1 DNA Repair Drugs Industry Trends
  2. 2.2 DNA Repair Drugs Industry Drivers
  3. 2.3 DNA Repair Drugs Industry Opportunities and Challenges
  4. 2.4 DNA Repair Drugs Industry Restraints
3 DNA Repair Drugs Market by Company
  1. 3.1 Global DNA Repair Drugs Company Revenue Ranking in 2025
  2. 3.2 Global DNA Repair Drugs Revenue by Company (2021-2026)
  3. 3.3 Global DNA Repair Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global DNA Repair Drugs Average Price by Company (2021-2026)
  5. 3.5 Global DNA Repair Drugs Company Ranking (2024-2026)
  6. 3.6 Global DNA Repair Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global DNA Repair Drugs Company Product Type and Application
  8. 3.8 Global DNA Repair Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global DNA Repair Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 DNA Repair Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 DNA Repair Drugs Market by Type
  1. 4.1 DNA Repair Drugs Type Introduction
  2. 4.1.1 PARP Inhibitors
  3. 4.1.2 Other
  4. 4.2 Global DNA Repair Drugs Sales Volume by Type
  5. 4.2.1 Global DNA Repair Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DNA Repair Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global DNA Repair Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global DNA Repair Drugs Sales Value by Type
  9. 4.3.1 Global DNA Repair Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global DNA Repair Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global DNA Repair Drugs Sales Value Share by Type (2021-2032)
5 DNA Repair Drugs Market by Application
  1. 5.1 DNA Repair Drugs Application Introduction
  2. 5.1.1 Oncological
  3. 5.1.2 Stroke
  4. 5.2 Global DNA Repair Drugs Sales Volume by Application
  5. 5.2.1 Global DNA Repair Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DNA Repair Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global DNA Repair Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global DNA Repair Drugs Sales Value by Application
  9. 5.3.1 Global DNA Repair Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DNA Repair Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global DNA Repair Drugs Sales Value Share by Application (2021-2032)
6 DNA Repair Drugs Regional Sales and Value Analysis
  1. 6.1 Global DNA Repair Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Repair Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global DNA Repair Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global DNA Repair Drugs Sales by Region (2027-2032)
  5. 6.3 Global DNA Repair Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global DNA Repair Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global DNA Repair Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global DNA Repair Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global DNA Repair Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America DNA Repair Drugs Sales Value (2021-2032)
  12. 6.6.2 North America DNA Repair Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe DNA Repair Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe DNA Repair Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific DNA Repair Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific DNA Repair Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America DNA Repair Drugs Sales Value (2021-2032)
  21. 6.9.2 South America DNA Repair Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa DNA Repair Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa DNA Repair Drugs Sales Value Share by Country, 2025 VS 2032
7 DNA Repair Drugs Country-level Sales and Value Analysis
  1. 7.1 Global DNA Repair Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Repair Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global DNA Repair Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global DNA Repair Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global DNA Repair Drugs Sales by Country (2027-2032)
  6. 7.4 Global DNA Repair Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global DNA Repair Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global DNA Repair Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt DNA Repair Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt DNA Repair Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt DNA Repair Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine
  8. 8.2.1 Jiangsu Hengrui Medicine Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Tesaro
  20. 8.4.1 Tesaro Company Information
  21. 8.4.2 Tesaro Business Overview
  22. 8.4.3 Tesaro DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tesaro DNA Repair Drugs Product Portfolio
  24. 8.4.5 Tesaro Recent Developments
  25. 8.5 National Institutes of Health
  26. 8.5.1 National Institutes of Health Company Information
  27. 8.5.2 National Institutes of Health Business Overview
  28. 8.5.3 National Institutes of Health DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 National Institutes of Health DNA Repair Drugs Product Portfolio
  30. 8.5.5 National Institutes of Health Recent Developments
  31. 8.6 National Health Service
  32. 8.6.1 National Health Service Company Information
  33. 8.6.2 National Health Service Business Overview
  34. 8.6.3 National Health Service DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 National Health Service DNA Repair Drugs Product Portfolio
  36. 8.6.5 National Health Service Recent Developments
  37. 8.7 KuDOS Pharmaceuticals
  38. 8.7.1 KuDOS Pharmaceuticals Company Information
  39. 8.7.2 KuDOS Pharmaceuticals Business Overview
  40. 8.7.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
  42. 8.7.5 KuDOS Pharmaceuticals Recent Developments
  43. 8.8 Karyopharm Therapeutics
  44. 8.8.1 Karyopharm Therapeutics Company Information
  45. 8.8.2 Karyopharm Therapeutics Business Overview
  46. 8.8.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
  48. 8.8.5 Karyopharm Therapeutics Recent Developments
  49. 8.9 Jonsson Comprehensive Cancer Center
  50. 8.9.1 Jonsson Comprehensive Cancer Center Company Information
  51. 8.9.2 Jonsson Comprehensive Cancer Center Business Overview
  52. 8.9.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
  54. 8.9.5 Jonsson Comprehensive Cancer Center Recent Developments
  55. 8.10 German Breast Group
  56. 8.10.1 German Breast Group Company Information
  57. 8.10.2 German Breast Group Business Overview
  58. 8.10.3 German Breast Group DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 German Breast Group DNA Repair Drugs Product Portfolio
  60. 8.10.5 German Breast Group Recent Developments
  61. 8.11 Georgetown University
  62. 8.11.1 Georgetown University Company Information
  63. 8.11.2 Georgetown University Business Overview
  64. 8.11.3 Georgetown University DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Georgetown University DNA Repair Drugs Product Portfolio
  66. 8.11.5 Georgetown University Recent Developments
  67. 8.12 Genentech
  68. 8.12.1 Genentech Company Information
  69. 8.12.2 Genentech Business Overview
  70. 8.12.3 Genentech DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Genentech DNA Repair Drugs Product Portfolio
  72. 8.12.5 Genentech Recent Developments
  73. 8.13 Cambridge University Hospitals NHS Foundation Trust
  74. 8.13.1 Cambridge University Hospitals NHS Foundation Trust Company Information
  75. 8.13.2 Cambridge University Hospitals NHS Foundation Trust Business Overview
  76. 8.13.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
  78. 8.13.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments
  79. 8.14 British Columbia Cancer Agency
  80. 8.14.1 British Columbia Cancer Agency Company Information
  81. 8.14.2 British Columbia Cancer Agency Business Overview
  82. 8.14.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
  84. 8.14.5 British Columbia Cancer Agency Recent Developments
  85. 8.15 Bristol Myers Squibb
  86. 8.15.1 Bristol Myers Squibb Company Information
  87. 8.15.2 Bristol Myers Squibb Business Overview
  88. 8.15.3 Bristol Myers Squibb DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
  90. 8.15.5 Bristol Myers Squibb Recent Developments
  91. 8.16 ARCAGY/ GINECO GROUP
  92. 8.16.1 ARCAGY/ GINECO GROUP Company Information
  93. 8.16.2 ARCAGY/ GINECO GROUP Business Overview
  94. 8.16.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
  96. 8.16.5 ARCAGY/ GINECO GROUP Recent Developments
  97. 8.17 4SC AG
  98. 8.17.1 4SC AG Company Information
  99. 8.17.2 4SC AG Business Overview
  100. 8.17.3 4SC AG DNA Repair Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 4SC AG DNA Repair Drugs Product Portfolio
  102. 8.17.5 4SC AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DNA Repair Drugs Value Chain Analysis
  2. 9.1.1 DNA Repair Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DNA Repair Drugs Sales Mode & Process
  6. 9.2 DNA Repair Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DNA Repair Drugs Distributors
  9. 9.2.3 DNA Repair Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst